Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs.
Twenty-one dogs with idiopathic superficial recurrent pyoderma were entered into a double-blind, placebo-controlled study to evaluate the efficacy of a commercial staphylococcal bacterin. The study spanned an 18-week period. All dogs were administered sodium oxacillin orally for the initial 6 weeks of the study. Dogs were given the bacterin or placebo SC, twice weekly at 3- or 4-day intervals, beginning at week 0 and continuing for 18 weeks. Dogs given antibiotics plus the bacterin (n = 13) had a significantly (P less than 0.05) better treatment response than those given antibiotic plus placebo.
DeBoer
D J
DJ
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison 53706.
Moriello
K A
KA
Thomas
C B
CB
Schultz
K T
KT
D000818:Animals; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004311:Double-Blind Method; D007279:Injections, Subcutaneous; D010068:Oxacillin / Q000627:therapeutic use*; D011711:Pyoderma / Q000188:drug therapy / Q000662:veterinary*; D012008:Recurrence; D013209:Staphylococcal Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D013209:Staphylococcal Vaccines; D010068:Oxacillin